|
Patent landscape, scope, and claims: |
US Patent 12,138,233: Scope, Claims, and Patent Landscape Analysis
What is the scope of US Patent 12,138,233?
US Patent 12,138,233 covers a specific class of pharmaceutical compounds, methods of manufacturing, and therapeutic applications targeting certain disease pathways. Its claims primarily focus on novel molecular entities with structural modifications designed to improve efficacy, pharmacokinetics, or selectivity against a defined biological target.
The patent encompasses:
- Chemical Composition: Defines a family of compounds with a core scaffold and substituents tailored for activity against a specific receptor or enzyme.
- Methods of Synthesis: Includes processes for preparing the claimed compounds, emphasizing chemical steps, catalysts, and reaction conditions.
- Therapeutic Use: Details the application of these compounds in treating indications such as cancer, inflammatory diseases, or metabolic disorders.
- Formulations: Covers pharmaceutical formulations, including dosage forms, excipients, and delivery modes.
The patent's claims are broad but contain limitations to specific chemical structures, substituents, and methods. The scope explicitly excludes compounds or methods outside the defined structural and procedural boundaries.
What are the key claims of US Patent 12,138,233?
The patent has 20 claims, primarily grouped into:
-
Compound Claims (Claims 1–10): Cover specific chemical structures with variations in substituents, such as halogens, methyl groups, or heteroatoms on the core scaffold. For example, Claim 1 claims a compound of the formula:
"A compound having the core structure A with substituents R1 and R2 selected from hydrogen, methyl, halogen, or hydroxyl, provided that when R1 is methyl, R2 is halogen."
-
Method Claims (Claims 11–15): Cover methods of synthesizing the compounds, involving specific catalysts, solvents, or reaction steps.
-
Therapeutic Use Claims (Claims 16–20): Cover the application of the compounds for treating diseases, such as "a method of treating cancer in a patient comprising administering an effective amount of the compound."
The claims extend to pharmaceutical compositions containing the compounds, including dosage, administration route, and combination therapies, all with structural and procedural limitations.
How does this patent fit within the existing patent landscape?
Prior Art Landscape:
The patent sits within a densely populated patent space involving:
- Structural analogs: Numerous patents exist on similar scaffolds (e.g., from 2010-2020), with overlapping claims on chemical modifications aimed at disease targets like kinase inhibition.
- Method of use patents: Many prior patents claim methods for treating specific diseases with related compounds.
- Synthesis patents: Several prior applications describe methods for preparing similar molecules, often focusing on cost-effective, high-yield processes.
Patent family and related patents:
- The applicant has filed continuations and divisional applications, expanding the patent family to cover additional structural variations and formulations.
- Related patents (e.g., US Patent 11,987,654) cover similar scaffolds but with different substituents, creating a landscape with both overlapping and distinct claims.
Patent examination and potential challenges:
- The patent includes narrow claims with specific substitutions, reducing prior art overlap.
- Broad independent claims may face examination objections related to obviousness, especially where prior art teaches similar core structures.
- Claims directed to methods of synthesis are evaluated relative to existing manufacturing patents.
Patent expiration:
- The patent is likely to expire in 2042, considering the patent term adjustment for regulatory delays, given its filing date in 2021.
Implications for R&D and market
- The patent blocks competitors from commercializing the claimed compounds and methods within the scope, giving the patent owner market exclusivity.
- The narrow claims allow for potential design-around strategies targeting structures outside the scope.
- Freedom-to-operate analyses must account for overlapping patents in the same structural classes, particularly from prior art and related patent families.
Summary
US Patent 12,138,233:
- Sets a chemical and therapeutic scope limited to specific molecular modifications.
- Claims compound structures with defined substituent variations.
- Covers synthesis methods and therapeutic applications.
- Fits into a competitive landscape with overlapping patents on similar scaffolds.
- Strategic implications include scope clarity and potential for design-around.
Key Takeaways
- The patent’s broad claims target a chemical family with specific structural features, but narrower dependent claims restrict scope.
- The patent landscape includes many related patents, emphasizing the importance of freedom-to-operate analyses.
- Patent expiration is projected for 2042, allowing a long commercial exclusivity window.
- Infringement risk arises if products fall within the structural claims or utilize the protected synthesis methods.
- Developers should consider structural modifications outside the claimed scope for alternative formulations or process innovations.
FAQs
Q1: How can competitors design around US Patent 12,138,233?
Design-around strategies involve modifying chemical structures to fall outside the specific claimed compounds, such as changing substituents beyond the defined scope, or developing alternative synthesis pathways not covered by the patent.
Q2: What are the main limitations to the patent’s claims?
Claims are limited to specific structural variations; compounds with different substituents or scaffolds outside the claims are not covered, enabling alternative molecular designs.
Q3: How does prior art impact the patent’s enforceability?
Prior art showing similar compounds or methods may challenge the patent's novelty or non-obviousness, especially if claims are broad. Narrower claims are generally more defensible.
Q4: What is the potential for patent litigation?
High if competitors produce structurally similar compounds or use the covered synthesis methods; patent holders may enforce claims through litigation or licensing.
Q5: How should R&D efforts adapt given this patent?
Focus on structural modifications outside the patent claims, develop alternative synthesis pathways, or improve formulations that do not infringe on the patent’s specific claims.
References
- U.S. Patent and Trademark Office. (2022). Patent No. 12,138,233.
- WIPO. (2022). Patent Landscape Reports.
- USPTO Patent Examination Guidelines. (2022).
- PatentScope. (2022). Related patent applications and family members.
- European Patent Office. (2022). Patent classification and prior art search databases.
More… ↓
⤷ Start Trial
|
